With the new classification of chronic myeloproliferative disorders, and the rise of interest in molecularly targeted therapies, this timely text brings together international experts on the topic to discuss the current technologies and their implications for the treatment of patients.This title comprehensively covers chronic myeloid leukemia and P

chapter 3|11 pages

Chapter 3

chapter 5|12 pages

Chapter 5

chapter 6|11 pages

Chapter 6

chapter 7|14 pages

Chapter 7

chapter 8|15 pages

Chapter 8

chapter 12|14 pages

Chapter 12

chapter 13|13 pages

Systemic mastocytosis

chapter 14|12 pages

Polycythemia vera

chapter 15|12 pages

Chapter 15

chapter 16|14 pages

Chapter 16